Health is at the core of Europe’s security— and its global competitiveness.

A recent Science|Business and Novartis panel underscored the need to strengthen Europe’s ability to innovate and respond to future crises.

🔹 Advancing Innovation: Europe must close the gap in translational research, incentivize private investment, and create competitive ecosystems to lead in advanced therapies and crisis-ready medicines.

🔹 Building Resilience: Stockpiling essential medical supplies and reserving production capacity are key to preparedness but must align with a robust R&D framework to meet future challenges.

To remain globally competitive, Europe must prioritize health innovation, ensuring the tools and industries needed for security also drive economic leadership.